Diagnosing bone metastasis typically involves a combination of symptom evaluation, blood tests, imaging scans, and sometimes a tissue biopsy. The process usually starts when a person with a known cancer develops new bone pain, or when routine imaging during cancer treatment reveals suspicious changes. In some cases, bone metastasis is the first sign that cancer has spread, discovered before the primary tumor is even identified.
Symptoms That Trigger the Workup
Bone pain is the most common reason doctors begin investigating for metastasis. The pain tends to come on gradually, feels deep or boring, and characteristically worsens at night. It can also flare with weight-bearing activities like standing or walking. Other red flags include unintentional weight loss, an enlarging lump near the area of concern, or a fracture that happens without significant trauma.
The spine is the most common site for bone metastasis, which means some people first notice neurological symptoms rather than simple pain. If a metastatic tumor compresses a nerve root, you might feel sharp, radiating pain that differs from typical back soreness. In more serious cases, spinal cord compression can cause limb weakness, numbness below a certain point on the body, or problems with bladder and bowel control. Spinal cord compression is treated as an oncologic emergency because delays can lead to permanent damage.
Which Cancers Spread to Bone Most Often
Not all cancers carry the same risk. Over a five-year period, prostate cancer has the highest incidence of bone metastasis at roughly 52%, followed by breast cancer at 41%, head and neck cancers at 36%, and lung cancer at 33%. This means doctors monitoring patients with these cancers are particularly alert to new bone complaints and often include skeletal screening as part of routine follow-up.
Blood Tests That Raise Suspicion
Blood work alone cannot confirm bone metastasis, but certain markers can strengthen the suspicion and guide the decision to order imaging. The two most telling are alkaline phosphatase (ALP) and serum calcium.
ALP is an enzyme produced by the liver and by bone-building cells. When cancer disrupts normal bone, ALP levels often climb. Calcium levels can also rise because the destruction of bone releases stored calcium into the bloodstream. In studies of cancer patients, both elevated ALP and elevated calcium were independently associated with bone metastasis. These markers are highly specific, meaning that when they’re abnormal, the chance of metastasis being present is significant, around 92 to 93%. However, their sensitivity is lower, so normal levels don’t rule it out. A drop in hemoglobin has also been identified as a contributing risk factor, since cancer in the bone marrow can interfere with blood cell production.
Bone Scans: The Traditional First Step
The technetium-99m bone scan (bone scintigraphy) has been a workhorse in oncology for decades. You receive an injection of a mildly radioactive tracer that collects in areas of active bone turnover. A few hours later, a gamma camera scans your entire skeleton. Any spot where bone is being rapidly broken down or rebuilt lights up as a “hot spot.”
Bone scans are good at surveying the whole skeleton in one session, with a sensitivity around 89.5% for detecting metastatic lesions. The trade-off is specificity: arthritis, old fractures, and infections can also cause hot spots, so an abnormal bone scan often needs follow-up imaging to confirm that the finding is actually cancer. Specificity sits at roughly 92%, which is reasonable but leaves room for false positives.
PET/CT: Higher Accuracy, More Detail
PET/CT scanning combines a metabolic tracer (typically a glucose-based radiotracer) with a CT scan to produce both functional and anatomical images. This combination outperforms bone scans, standalone CT, and standalone PET across the board. In head-to-head comparisons, PET/CT achieved 97.8% sensitivity and 98.2% specificity for bone metastasis, meaning it catches nearly all true lesions while producing very few false alarms.
A newer tracer, sodium fluoride (NaF), is sometimes used specifically for bone PET/CT. It works through the same uptake mechanism as the traditional bone scan tracer but clears from the blood faster and concentrates in bone at roughly twice the rate. This produces sharper images in less time. Adding the CT component further improves specificity by giving doctors a clear look at the anatomy behind each hot spot.
PET/CT is not always the first test ordered, partly because of cost and availability. Many oncologists still start with a conventional bone scan and escalate to PET/CT when results are inconclusive or when a more precise map of disease is needed for treatment planning.
MRI: Best for Bone Marrow Involvement
MRI excels at visualizing soft tissue, which makes it the preferred tool when doctors need to see what’s happening inside the marrow cavity. Its sensitivity for bone metastasis is about 95%, with specificity around 90%. What makes MRI particularly valuable is its ability to detect cancer deposits inside bone marrow before those deposits have destroyed enough outer bone to show up on a bone scan or CT. In other words, MRI can catch metastasis at an earlier stage than most other imaging.
MRI is also the go-to scan when spinal cord compression is suspected. It can show exactly where a tumor is pressing on the spinal cord or nerve roots, which directly determines how urgently treatment needs to happen. The main limitation is that MRI typically focuses on a specific body region rather than scanning the entire skeleton, so it’s better for targeted investigation than for a full-body survey.
CT Scans and Their Role
CT scans are fast and widely available, and they’re often the imaging that first raises suspicion. A CT ordered for another reason, like monitoring lung cancer, might incidentally show bone destruction. On its own, CT has a sensitivity of about 70% for bone metastasis, which is the lowest among the major imaging options. It’s best at detecting lesions that have already caused visible structural damage to bone, but it can miss earlier marrow-only disease. CT is most useful as part of the PET/CT combination or as a complement to other scans.
Confirming With a Biopsy
Imaging can strongly suggest bone metastasis, but a biopsy provides definitive proof. This is especially important when there’s no known primary cancer, when the imaging findings are ambiguous, or when confirming the diagnosis would change the treatment plan.
The most common approach is a core needle biopsy, where a radiologist uses CT or ultrasound guidance to insert a needle into the suspicious bone lesion and extract a small cylinder of tissue. It’s typically done under local anesthesia as an outpatient procedure. In some cases, a fine-needle aspiration is used instead, though this collects less tissue and can make precise classification harder. Open surgical biopsies are reserved for situations where needle biopsies haven’t provided enough material for a clear answer.
Once the tissue reaches the pathology lab, it undergoes several layers of analysis. Pathologists examine the cells under a microscope to determine whether they’re cancerous and, if so, what type. Immunohistochemistry uses antibody-based stains to identify specific proteins on the cell surface, helping to trace the cancer back to its organ of origin. For instance, a bone lesion in someone without a known cancer history might stain positive for markers that point to breast, prostate, or lung tissue. Molecular and genetic testing can identify specific mutations or chromosomal rearrangements that further classify the tumor and may open the door to targeted therapies.
Skeletal-Related Events as Diagnostic Clues
Sometimes bone metastasis is diagnosed not through a planned workup but through a complication. These complications, collectively called skeletal-related events, include pathologic fractures (bones breaking under normal stress), spinal cord compression, and bone pain severe enough to require radiation. A fracture that occurs without adequate trauma in someone with a history of cancer is treated as metastasis until proven otherwise. Similarly, sudden-onset back pain with leg weakness in a cancer patient prompts emergency imaging, usually an MRI, to check for cord compression.
Pathologic fractures in the spine present with pain that typically worsens when sitting or standing. Fractures in the long bones of the arms or legs can happen during everyday activities. In either case, the fracture itself often leads to the imaging that reveals the underlying metastatic disease, particularly in patients whose primary cancer was previously considered low-risk for spread.